NTL HEALTHCARE, a women’s health AI company, has launched CerviCARE AI AT worldwide. This on-premises solution is an extension of its AI-powered cervical screening system, CerviCARE AI.
“As global adoption of medical AI continues to grow, healthcare institutions are placing increasing importance not only on AI performance but also on how medical data is processed and managed within their own IT environments,” said Tae-hee Kim, CEO of NTL HEALTHCARE. “CerviCARE AI AT maintains the core capabilities of CerviCARE AI while offering healthcare institutions a new deployment option.”
CerviCARE AI AT
CerviCARE AI uses artificial intelligence to analyse cervical images and assist healthcare professionals with clinical decisions in cervical screening. CerviCARE AI AT offers an on-premises deployment, allowing AI analysis and data management within the institution’s IT environment.
It installs on local PCs and operates without a dedicated server or cloud infrastructure, minimising the need to transmit or store cervical images and related data outside the institution.
This approach lets institutions manage medical data within their own IT environments, providing greater control.
CerviCARE AI AT retains the core AI analysis capabilities and features of the SaaS version. Institutions can choose between SaaS and on-premises deployment based on their IT infrastructure, security policies, and data management needs.
The new version adds DICOM file generation, allowing cervical images and related information to be converted and managed in a standardised medical imaging format.
